News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cox Russell J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 1,950,000 options to buy
@ $0.3, valued at
$585k
|
|
| 06/09/2023 |
4
| Cox Russell J. (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.26, valued at
$44.1k
|
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 43,000 options to buy
@ $0.73, valued at
$31.4k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.8, valued at
$272k
|
|
| 06/18/2020 |
4
| Cox Russell J. (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 23,500 options to buy
@ $12.1, valued at
$284.4k
|
|
| 06/10/2020 |
4
| Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 28,100 options to buy
@ $8.89, valued at
$249.8k
|
|
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 12,400 options to buy
@ $6.33, valued at
$78.5k
|
|
| 02/12/2019 |
4
| Cox Russell J. (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 7,200 shares
@ $16, valued at
$115.2k
|
|
| 01/14/2019 |
4
| Cox Russell J. (CEO) has filed a Form 4 on VITAL THERAPIES INC|
Txns:
| Disposed/sold 1,588,832 options to buy
@ $6.3, valued at
$10M
Granted 1,854,376 restricted stock units
@ $0 |
|
| 06/08/2018 |
4
| Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 18,400 options to buy
@ $10.28, valued at
$189.2k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2017 |
4
| Cox Russell J. (EVP & COO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Exercised 44,200 options to buy
@ $8.23, valued at
$363.8k
Exercised 4,867 options to buy
@ $46.83, valued at
$227.9k
Exercised 1,691 options to buy
@ $59.13, valued at
$100k
|
|
| 12/05/2017 |
4
| Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.73, valued at
$141.9k
|
|
| 08/09/2017 |
4
| Cox Russell J. (EVP & COO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 978 shares
@ $155.56, valued at
$152.1k
|
|
| 03/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/10/2016 |
4
| Cox Russell J. (EVP & COO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 978 shares
@ $149.02, valued at
$145.7k
Paid exercise price by delivering 4,565 shares
@ $150.01, valued at
$684.8k
Sold 4,000 shares
@ $148.66, valued at
$594.6k
|
|
| 05/19/2016 |
4
| Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $7.28, valued at
$72.8k
|
|
| 04/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/12/2016 |
4
| Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc. |
| 03/09/2016 |
4
| Cox Russell J. (EVP & COO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 1,550 shares
@ $127.84, valued at
$198.2k
|
|
| 03/02/2016 |
4
| Cox Russell J. (EVP & COO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 939 shares
@ $121.58, valued at
$114.2k
|
|
| 09/04/2013 |
4
| Cox Russell J. (EVP & Chief Commercial Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 1,000 shares
@ $88.16, valued at
$88.2k
|
|
| 08/13/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/02/2013 |
4
| Cox Russell J. (EVP & Chief Commercial Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 2,000 shares
@ $76.22, valued at
$152.4k
|
|
| 03/06/2013 |
4
| Cox Russell J. (EVP & Chief Commercial Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 13,750 shares
@ $0
Granted 25,809 options to buy
@ $59.13, valued at
$1.5M
Granted 1,691 options to buy
@ $59.13, valued at
$100k
|
|
| 10/03/2012 |
4
| Cox Russell J. (EVP & Chief Commercial Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 5,000 shares
@ $57.24, valued at
$286.2k
|
|
| 08/13/2012 |
4
| Cox Russell J. (EVP & Chief Commercial Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 35,000 shares
@ $0
Granted 70,000 options to buy
@ $46.83, valued at
$3.3M
|
|
| 06/04/2012 |
4
| Cox Russell J. (EVP & Chief Commercial Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Acquired 1,007 shares
@ $14.89, valued at
$15k
|
|
|
|
|